Fontan Udenafil Exercise Longitudinal Assessment Trial - 2for Single Ventricle Heart DiseaseSites in Dallas, Houston +35 more locationsSponsor: Mezzion Pharma Co. LtdSex: All·Age: 12 - 18Code: NCT05918211·Phase 3·Recruiting·Listed Jun 2023Apply to this trial
Immune Modulation During Palynziq® Treatment in Adults (IMPALA)for PhenylketonuriaDrug: PalynziqSites in Dallas +11 more locationsSponsor: BioMarin PharmaceuticalSex: All·Age: 18 - 65Code: NCT07477691·Phase 4·Recruiting·Listed Mar 2026Apply to this trial
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancerfor Gastric CancerSites in Dallas, Tyler +13 more locationsSponsor: Daiichi SankyoSex: All·Age: 18+Code: NCT06731478·Phase 3·Recruiting·Listed Dec 2024Apply to this trial
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.for Hematuria - Cause Not KnownSites in Dallas, Austin +16 more locationsSponsor: Pacific Edge LimitedSex: All·Age: 18 - 88Code: NCT06394869·Recruiting·Listed May 2024Apply to this trial
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)for Healthy Volunteers, Pulmonary Arterial HypertensionSites in Dallas, Austin +18 more locationsSponsor: Novartis PharmaceuticalsSex: All·Age: 18 - 100·Accepts healthy volunteersCode: NCT06649110·Phase 1, Phase 2·Recruiting·Listed Oct 2024Apply to this trial
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancerfor Ovarian CancerSites in Dallas +20 more locationsSponsor: Regeneron PharmaceuticalsSex: Female·Age: 18+Code: NCT06787612·Phase 2·Recruiting·Listed Jan 2025Apply to this trial
Galvanize Prospective/Retrospective Pulsed Electric Field Device Registryfor Soft Tissue LesionSites in Dallas, Tyler +9 more locationsSponsor: Galvanize Therapeutics, Inc.Sex: All·Age: 18 - 100Code: NCT05851430·Recruiting·Listed May 2023Apply to this trial
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infectionsfor NeutropeniaSites in Dallas, Fort Worth +20 more locationsSponsor: X4 PharmaceuticalsSex: All·Age: 12+Code: NCT06056297·Phase 3·Recruiting·Listed Sep 2023Apply to this trial
MEASuRE: Metreleptin Effectiveness And Safety Registryfor Generalised LipodystrophySites in Dallas +8 more locationsSponsor: Chiesi Farmaceutici S.p.A.Sex: All·Age: All agesCode: NCT02325674·Recruiting·Listed Dec 2014Apply to this trial
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGNfor IC-MPGNDrug: IptacopanSites in Dallas, Temple +20 more locationsSponsor: Novartis PharmaceuticalsSex: All·Age: 12 - 60Code: NCT05755386·Phase 3·Recruiting·Listed Mar 2023Apply to this trial
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancerfor Gastric AdenocarcinomaSites in Dallas +9 more locationsSponsor: Astellas Pharma Global Development, Inc.Sex: All·Age: 18+Code: NCT05365581·Phase 1·Recruiting·Listed May 2022Apply to this trial
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)for Complex Cardiovascular Surgery With Cardiopulmonary BypassSites in Dallas +9 more locationsSponsor: CSL BehringSex: All·Age: 18+Code: NCT07094087·Phase 3·Recruiting·Listed Jul 2025Apply to this trial
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Studyfor Lower Respiratory Tract InfectionSites in Dallas, Houston +17 more locationsSponsor: Ansun Biopharma, Inc.Sex: All·Age: All agesCode: NCT03808922·Phase 3·Recruiting·Listed Jan 2019Apply to this trial
A Long Term, Post-marketing Study of Immune Response in Patients Receiving Palynziq Treatment for PKU (PALisade)for Phenylketonuria (PKU)Drug: PalynziqSites in Dallas +10 more locationsSponsor: BioMarin PharmaceuticalSex: All·Age: All agesCode: NCT06305234·Recruiting·Listed Mar 2024Apply to this trial
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphomafor Relapsed or Refractory T Cell LymphomaSites in Dallas, Houston +17 more locationsSponsor: Ono Pharmaceutical Co., Ltd.Sex: All·Age: 18+Code: NCT05079282·Phase 1·Recruiting·Listed Oct 2021Apply to this trial
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseasesfor Muscular DiseasesSites in Dallas, Houston +11 more locationsSponsor: Arcellx, Inc.Sex: All·Age: 18+Code: NCT06626919·Phase 1·Recruiting·Listed Oct 2024Apply to this trial
A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CFfor Cystic FibrosisSites in Dallas +12 more locationsSponsor: ReCode TherapeuticsSex: All·Age: 18 - 60·Accepts healthy volunteersCode: NCT06237335·Phase 2·Recruiting·Listed Feb 2024Apply to this trial
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Yearsfor Motor FunctionSites in Dallas +7 more locationsSponsor: GuerbetSex: All·Age: 18 - 64Code: NCT04373564·Phase 4·Recruiting·Listed May 2020Apply to this trial
A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expressionfor Recurrent Ovarian CancerSites in Dallas +6 more locationsSponsor: AbbVieSex: Female·Age: 18+Code: NCT06365853·Phase 2·Recruiting·Listed Apr 2024Apply to this trial
US National OCS Liver Perfusion (OLP) Registryfor Liver TransplantSites in Dallas, Houston +20 more locationsSponsor: TransMedicsSex: All·Age: All agesCode: NCT05940857·Recruiting·Listed Jul 2023Apply to this trial
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmytofor Urothelial CarcinomaSites in Dallas, Houston +20 more locationsSponsor: UroGen Pharma Ltd.Sex: All·Age: 18+Code: NCT05874921·Recruiting·Listed May 2023Apply to this trial
A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromesfor Higher-risk Myelodysplastic SyndromesSites in Dallas +13 more locationsSponsor: AkesoSex: All·Age: 18+Code: NCT06196203·Phase 2·Recruiting·Listed Jan 2024Apply to this trial
Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophyfor Generalized LipodystrophySites in Dallas +1 more locationSponsor: Regeneron PharmaceuticalsSex: All·Age: 2+Code: NCT07220785·Phase 3·Recruiting·Listed Oct 2025Apply to this trial
Open-label Extension Study to Evaluate Metreleptin in Patients With Partial Lipodystrophyfor Familial Partial LipodystrophySites in Dallas +6 more locationsSponsor: Chiesi Farmaceutici S.p.A.Sex: All·Age: 13+Code: NCT06679270·Phase 3·Recruiting·Listed Nov 2024Apply to this trial
Infant Formula in Infants and Children With Cow's Milk Allergyfor Cow's Milk AllergySites in Dallas +7 more locationsSponsor: Abbott NutritionSex: All·Age: 3 Months - 12Code: NCT06456541·Recruiting·Listed Jun 2024Apply to this trial
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Diseasefor Metastatic Breast Cancer in the LiverSites in Dallas +3 more locationsSponsor: Delcath Systems Inc.Sex: All·Age: 18+Code: NCT06875128·Phase 2·Recruiting·Listed Mar 2025Apply to this trial
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinomafor Adenocarcinoma of LungSites in Dallas +4 more locationsSponsor: Lantern Pharma Inc.Sex: All·Age: 18+Code: NCT05456256·Phase 2·Recruiting·Listed Jul 2022Apply to this trial
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Studyfor Severe Hemophilia A1 location in DallasSponsor: OctapharmaSex: Male·Age: 12+Code: NCT05935358·Phase 4·Recruiting·Listed Jul 2023Apply to this trial
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).for IGF1 DeficiencySites in Dallas +4 more locationsSponsor: Esteve Pharmaceuticals, S.A.Sex: All·Age: 2 - 18Code: NCT00903110·Recruiting·Listed May 2009Apply to this trial
A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumorsfor Advanced Solid TumorSites in Dallas +3 more locationsSponsor: FBD Biologics LimitedSex: All·Age: 18+Code: NCT05892718·Phase 1·Recruiting·Listed Jun 2023Apply to this trial
A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcelfor Cerebral Adrenoleukodystrophy (CALD)Sites in Dallas +2 more locationsSponsor: Genetix Biotherapeutics Inc.Sex: Male·Age: All agesCode: NCT06224413·Recruiting·Listed Jan 2024Apply to this trial
The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)for Lower Respiratory Tract InfectionSites in Dallas +7 more locationsSponsor: MeMed Diagnostics Ltd.Sex: All·Age: 18 - 99Code: NCT05762302·Recruiting·Listed Mar 2023Apply to this trial
Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)for Heart Failure With Preserved Ejection Fraction (HFpEF)Sites in Dallas +1 more locationSponsor: Secretome TherapeuticsSex: All·Age: 18+Code: NCT06560762·Phase 1·Recruiting·Listed Aug 2024Apply to this trial
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)for GliomaSites in Dallas, San Antonio +1 more locationSponsor: Plus TherapeuticsSex: All·Age: 18+Code: NCT01906385·Phase 1, Phase 2·Recruiting·Listed Jul 2013Apply to this trial
Longitudinal Bladder Cancer Study for Tumour Recurrencefor Urothelial Bladder CancerSites in Dallas +5 more locationsSponsor: Pacific Edge LimitedSex: All·Age: 18+Code: NCT05080998·Recruiting·Listed Oct 2021Apply to this trial
The Return of Cardiovascular Information Trial (RECITE)for Health Curiosity1 location in DallasSponsor: University of Texas Southwestern Medical CenterSex: All·Age: 35+·Accepts healthy volunteersCode: NCT07613853·Recruiting·Listed May 2026Apply to this trial
Duchenne Electronic Health Record Studyfor Duchenne Muscular Dystrophy (DMD)Sites in Dallas +9 more locationsSponsor: The Duchenne RegistrySex: All·Age: All agesCode: NCT07609394·Recruiting·Listed May 2026Apply to this trial
FOCUS Bipolar: Families Opening Conversations for Understanding Signsfor Bipolar Disorder (BD)1 location in DallasSponsor: University of Texas Southwestern Medical CenterSex: All·Age: 7+·Accepts healthy volunteersCode: NCT07622927·Recruiting·Listed Jun 2026Apply to this trial
Examining the Feasibility of Using Pressure Gradient Regulated Automated Cerebral Spinal Fluid Drainage During External Lumbar Drain Trialsfor NPH (Normal Pressure Hydrocephalus)1 location in DallasSponsor: University of Texas Southwestern Medical CenterSex: All·Age: 60 - 99Code: NCT07494812·Recruiting·Listed Mar 2026Apply to this trial
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)for Optic NeuritisSites in Dallas +28 more locationsSponsor: Mayo ClinicSex: All·Age: 18+Code: NCT07100990·Phase 3·Recruiting·Listed Aug 2025Apply to this trial